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Transport across biological membranes is fundamental for cell survival and is mainly 
accomplished by specialized membrane proteins known as transporters. The ABC-type 
transporters constitute one of the largest and most diverse transporter superfamilies and are 
found in all three domains of life (Archaea, Bacteria and Eukarya). These permeases utilize the 
binding and hydrolysis of ATP to power the directional transport of a wide variety of substrates 
across membranes, ranging from ions to macromolecules. The ABC transporters have a 
modular architecture comprising two transmembrane domains (TMDs) that form the 
translocation pore and two nucleotide-binding domains (NBDs) that hydrolyse the necessary 
ATP for the translocation process. 
Until the last few years, NBDs were thought to be exclusive of each transporter complex, 
however it was discovered that several bacterial species ABC transporters share the same 
energy-generating component. In the Gram-positive model organism Bacillus subtilis ten ABC 
transporters are predicted to be involved in sugar uptake and eight of these systems do not 
display a gene encoding a putative NBD protein in their vicinity. Recent studies, demonstrated 
that MsmX interacts with several of these eight distinct ABC sugar importers. Thus, unlike other 
NBDs, MsmX was shown to be multitask serving as energy-generating component to several 
sugar importers. Other examples of multitask ATPases are also found in Streptococcus and 
Streptomyces species and are involved in the uptake of carbohydrates. So a better 
understanding of these multitask ATPases may have an important impact in therapy 
development for pathogenic bacteria since carbohydrate utilization is essential for 
microorganisms survival. 
In this work we demonstrate that B. subtilis can be used as a model to study multitask 
ATPases from other Gram-positive pathogenic species. A genetic system was developed to test 
in vivo the functionality of MsmX homologs from pathogenic species: Bacillus thuringiensis, 
Staphylococcus aureus and Streptococcus pneumoniae. The results show that the proteins are 
capable to play the role of MsmX in the cell, although with a different degree of efficiency. 
Functional analysis studies of MsmX indicate that modifications in the N- and C-terminal amino 
acid sequence do not affect its function. Moreover, by mutagenesis we show both in vitro an in 
vivo that the Lys 43 of MsmX, a conserved amino acid of NBDs, is essential for ATP hydrolysis. 
Additionally, the MsmX production and purification protocol was improved for further 
crystallography studies and biochemical characterization. 
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O transporte através de membranas biológicas é fundamental para a sobrevivência das 
células e é realizado, principalmente, por proteínas especializadas da membrana designadas 
como transportadores. Os transportadores do tipo ABC constituem uma das maiores e mais 
diversificadas superfamílias de transportadores existindo em todos os três domínios dos seres 
vivos (Archaea, Bacteria e Eukarya). Estas permeases utilizam a ligação e hidrólise do ATP 
como força motriz para o transporte de uma ampla variedade de substratos através da 
membrana, desde iões a macromoléculas. Os transportadores ABC têm uma arquitetura 
modular que compreende dois domínios transmembranares (TMDs), que formam o poro de 
translocação, e dois domínios de ligação a nucleótidos (NBDs), que hidrolisam o ATP 
necessário para o processo de translocação. 
Até recentemente, pensava-se que os NBDs eram exclusivos de cada complexo 
transportador, no entanto descobriu-se que vários transportadores ABC de procariontes 
partilham o mesmo componente de produção de energia. Na espécie Bacillus subtilis, 
organismo modelo de bactérias Gram-positivas, existem dez transportadores ABC que se 
prevêem estar envolvidos no transporte de açúcares, sendo que oito desses sistemas não 
exibem um gene codificante para uma NBD putativa na sua vizinhança. Estudos recentes 
demonstraram que o MsmX interage com vários desses oito importadores. Assim, ao contrário 
de outros NBDs, o MsmX mostrou ser multitarefa servindo como “motor” para vários 
importadores de açúcares. Outros exemplos de ATPases multitarefa são também encontrados 
em espécies de Streptococcus e Streptomyces, estando envolvidos no transporte de açúcares. 
Assim sendo, uma melhor compreensão destas ATPases multitarefa pode ter um impacto 
importante no desenvolvimento de tratamentos para infecções bacterianas, dado que a 
utilização de hidratos de carbono é essencial para a sobrevivência dos microrganismos. 
Neste trabalho demonstramos que B. subtilis pode ser usado como modelo para o estudo 
de ATPases multitarefa de outras espécies Gram-positivas patogénicas. De forma a testar in 
vivo a funcionalidade dos homólogos do MsmX provenientes de espécies patogénicas (Bacillus 
thuringiensis, Staphylococcus aureus e Streptococcus pneumoniae) foi desenvolvido um 
sistema genético. Os resultados mostram que as proteínas são capazes de desempenhar o 
papel do MsmX na célula, embora com diferentes graus de eficácia. Estudos funcionais do 
MsmX indicam que modificações na sequência de aminoácidos do N- e C-terminal não afectam 
a sua função. Além disso, mostramos através de mutagénese, tanto in vitro e in vivo, que a Lys 
43 do MsmX, um aminoácido conservado de NBDs, é essencial para a hidrólise de ATP. Além 
disso, o protocolo de produção e purificação do MsmX foi melhorado de modo a realizar 
estudos cristalográficos e caracterizar bioquimicamente a proteína. 
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1. General Introduction 
1.1. Membrane Transport Systems 
Living cells are separated from the  environment  by  lipid  membranes,  whereas  other 
subcellular  membranes  play  essential  roles  in  the  architecture  of  eukaryotic  cells (Seyffer 
and Tampé, 2014). Transport across biological membranes is fundamental for cell survival, 
which is accomplished, in the majority of the cases, by specialized membrane proteins that are 
known as transporters. These proteins are responsible for the regulated and selective passage 
of small molecules, ions and even some macromolecules into the cell or in the opposite 
direction (Higgins, 1992; Rees et al., 2009; Eitinger et al., 2010). 
The importance of membrane transport to the cell is exemplified by the fact that ~10% of 
the Escherichia coli genome has been classified as participating in transport processes and, 
overall, more than 550 different types of transporters have been identified (Rees et al., 2009). 
Bacillus subtilis possesses a similar percentage of transporters in the genome with minor 
differences. While E. coli has more sugar transporters, B. subtilis encodes more 
drug/hydrophobic exporters (Saier et al., 2002). 
Accordingly to the way solute transport is energized, membrane transporters are classified 
in three major groups: primary active transporters, secondary transporters and group 
translocators. Primary active transporters comprise very diverse protein families that use 
chemical, electrical or solar energy sources to transport substrates across the membrane 
against a concentration gradient. On the other hand secondary transporters often accumulate 
substrates in – or deplete them from – cells by using the energy stored in ion gradients, 
frequently Na+ or H+, to drive transport. This includes uniporters, antiporters, and symporters. 
Group translocators chemically modify the substrate during the transport reaction, as for 
example the phosphotransferase system (PTS) which transfers a phosphate group to the 
substrate once it enters the cell (Davidson et al., 2008; Jaehme and Slotboom, 2014). 
This dissertation will focus in one of the primary active transporters families: the ATP-
binding cassette (ABC) transporters. 
 
1.2. ABC-type Transport Systems 
The ABC transporters constitute one of the largest and most diverse transporter 
superfamilies (seven distinct subfamilies) and are found in all three domains of life (Archaea, 
 




Bacteria and Eukarya) (Yoshida et al., 1996; Rees et al., 2009; Seyffer and Tampé, 2014). 
These transporters use the binding and hydrolysis of ATP (phosphate bond between the γ- and 
the β-phosphate) to power the directional transport of a wide variety of substrates across 
membranes, ranging from ions to macromolecules (Rees et al., 2009; Seyffer and Tampé, 
2014; ter Beek et al., 2014). 
The designation ABC transporters acknowledges a highly conserved ATP-binding cassette, 
which is the most characteristic feature of this superfamily (Higgins, 1992). These systems are 
widespread among living organisms and have been found in all species from the microbe to 
man, with a high conservation of the primary sequence of the ATP-hydrolyzing domain and in 
the modular architecture (Higgins, 2001; Davidson et al., 2008). 
The first systems discovered and characterized in detail were the high-affinity histidine 
(HisJQMP) and maltose (MalEFGK) uptake systems of Salmonella enterica serovar 
typhimurium and E. coli in the 1970s (Davidson et al., 2008). Since then, a variety of systems 
have been identified both in prokaryotes and eukaryotes. In E. coli and B. subtilis ~80 and 59 
distinct systems were reported, respectively, while ~50 systems (five subfamilies) exist in 
humans. Plants genome, like Arabidopsis thaliana, has 4120 ABC systems. However, in relation 
to genome size, the highest number of ABC systems exists in bacteria (Rees et al., 2009; 
Eitinger et al., 2010; Seyffer and Tampé, 2014).  
In prokaryotes, these transporters are present in the plasma membrane with the ATP being 
hydrolyzed in the cytoplasmic side and transport a wide variety of substrates: sugars, amino 
acids, opines, peptides, phosphates, sulphates, vitamins, metallic cations, molybdenum and 
organo-iron complexes. Many of these transporters are central to antibiotic and antifungal 
resistance. In eukaryotes, the ABC transporters are found in organellar membranes with the 
hydrolysis taking place in the cytosolic side. The transporters from mitochondria and 
chloroplasts are an exception, because the domains responsible for the ATP hydrolysis are 
present in the matrix or stroma side. The ABC transporters found in humans handle antibiotics, 
toxins, vitamins, drugs, metals, peptides, ions, lipids, bile acids, polycarbonates and sterols. 
Dysfunctions in these systems are associated with genetic diseases such as cystic fibrosis, 
Tangier disease, obstetric cholestasis, and drug resistance of cancers. Here we will designate 
cis-side as the side where the ATP is bound and hydrolysed and the opposite side termed as 
trans-side (Quentin et al., 1999; Higgins, 2001; Seyffer and Tampé, 2014; ter Beek et al., 2014). 
 
The ABC-type transporters are importers, which move substrates from the trans-side to the 
cis-side, or exporters that transport the molecules from the cis-side to the trans-side. (ter Beek 
et al., 2014). Despite this distinction between importers and exporters, they all share a common 
structural organization. They have a modular architecture comprising two transmembrane 
 




domains (TMDs) that form the translocation pore and two nucleotide-binding domains (NBDs) 
that hydrolyze ATP (Eitinger et al., 2010). 
The TMDs are highly hydrophobic and each one, normally, contains six membrane-
spanning segments. These domains create the pathway for substrate transport and determine 
the substrate specificity of the transporter through substrate-binding sites (Higgins, 1992, 2001; 
Quentin et al., 1999). The NBDs are peripherally located at the cis-side of the membrane, where 
they associate with the TMDs, and are highly conserved in structure and sequence. There are 
some NBDs that do not interact with TMDs, being involved in other functions such as mRNA 
translation and DNA repair. However, for these exceptions the term “ABC transporter” is not 
applied and thus will not be discussed here (Higgins, 1992; Davidson et al., 2008; ter Beek et 
al., 2014). 
The individual domains of an ABC transporter are frequently expressed as individual 
polypeptides, often found in prokaryotic species, or are fused into larger, multifunctional 
polypeptides. When one of the four domains is absent, one of the remaining domains functions 
as a homodimer (Higgins, 1992, 2001; Seyffer and Tampé, 2014). 
In many ABC transporters auxiliary domains have been recruited for specific functions, 
such as the substrate-binding protein (SBP) a domain that binds to the substrate in the trans-
side of the membrane and delivers it to the membrane-associated transport complex. The SBPs 
are soluble and periplasmic in Gram-negative bacteria, while in Gram-positive bacteria they are 
anchored to the membrane via an N-terminal hydrophobic lipid extension due to inexistence of 
an outer membrane. Their presence gives specificity and a high degree of affinity for substrates 
to the transport systems (Quentin et al., 1999; Higgins, 2001).  
ABC Transporters Classes 
In contrast to the conserved NBDs, several unrelated folds of the TMDs have been found 
that do not share significant sequence similarity. Based in these different folds we can classify 
the transporters in four different classes: Importers Type I and II, Exporters and Energy 
Coupling Factor (ECF) transporters (Type III importers) (Figure 1.1; ter Beek et al., 2014). 
All three types of ABC importers are found only in prokaryotes, for the exception of ECF 
transporters which are also present in some plant organelles. Normally Type I importers are 
dedicated to the transport of compounds required in massive amounts (such as sugars and 
amino acids), whereas Type II importers and ECF transporters are responsible for the transport 
of compounds needed in small quantities (metal chelates, vitamins). Importers generally are 
selective for a single or a few related water-soluble substrates (Seyffer and Tampé, 2014; ter 
Beek et al., 2014). 
 




ABC transporters that play exporter functions can be found both in prokaryotes and 
eukaryotes, where they are involved in the transport of hydrophobic compounds such as lipids, 
fatty acids, cholesterol, and drugs. Some are called multidrug-resistant transporters because 
they can secret a large variety of drugs out of the cell. Also, they translocate larger molecules 
such as proteins (toxins, hydrolytic enzymes, S-layer proteins, lantibiotics, bacteriocins, and 
competence factors) (ter Beek et al., 2014). Note that it is not excluded that the identical fold 
exerts import and export functions in homologous proteins (Seyffer and Tampé, 2014). 




Figure 1.1 - Classes of ABC transporters. The four classes share a common structural 
organization: two NBDs (blue and sky blue) are attached to two TMDs (orange and yellow). Type I and II 
importers can have additional domains (green), which often have a regulatory function (C-terminal 
regulatory domain [CRD] fused to NBD). Type I and II importers have SBPs (magenta) located in the 
periplasm (Gram-negative bacteria) or external space (Gram-positive bacteria and Archaea) which deliver 





When the transporter is not translocating any substrate, it is in a resting-state conformation 
(Inward Open). In this conformation, the NBD dimer interface is open and the two TMDs line a 
cavity that is accessible from the cytoplasmic side of the membrane and is sealed by a 
hydrophobic gate on the outside. When substrate is present it binds to the SBP, which creates 
conformational changes in the TMDs and the NBDs. The NBDs come into closer proximity (the 
Pre-Translocation state) allowing ATP binding (Oldham et al., 2007; ter Beek et al., 2014). 
 




When ATP binds, the NBD dimer closes, with the two ATP molecules located at the 
interface, and the cavity between the two TMDs is open toward the outside (Outward Open). 
Then the SBP, which stabilizes in a conformation with decreased affinity to the substrate, 
releases the substrate into the cavity between the TMDs where it binds to a specific site. ATP 
hydrolysis does not appear to affect this state, but subsequent release of Pi and ADP is 
expected to allow the TMDs to return to a conformation with the cavity exposed to the 
cytoplasm (Post-hydrolysis open), which then results in the release of the substrate and 
completion of the transport cycle (Oldham et al., 2007; ter Beek et al., 2014). 
A key concept of this model is that the transition from the inward open to the outward open 
conformation is driven by substrate binding to the SBP instead of the binding of ATP to the 
NBDs (Oldham et al., 2007; ter Beek et al., 2014). The transport mechanism is summarized in 




Figure 1.2 - The transport mechanism of Type I importers. First the substrate (orange) binds to 
the SBP (green), which creates conformational changes in the TMDs (blue) and NBDs (purple), allowing 
binding of ATP (yellow). When ATP binds, the NBD dimer closes and the cavity between the two TMD is 
open toward the outside. Subsequent ATP hydrolysis and Pi release (blue circles) return the TMDs to the 
initial position, releasing the substrate to the cytoplasm. 
The Solute Binding Protein (SBP) 
The SBP is a soluble constituent of ABC importers that is located on the trans-side of the 
membrane. They vary in size from 25 kDa to 59 kDa and there is little sequence conservation 
between binding proteins for different substrates (Higgins, 1992; ter Beek et al., 2014). 
Depending on the type of cell wall the bacteria possess, the binding proteins can diffuse freely 
in the periplasm between the inner and the outer membrane (Gram-negative bacteria), or be 
 




anchored to the outer surface of the cell membrane via an N-terminal lipid moiety (Gram-
positive bacteria and archaea) or a Transmembrane helix (archaea). In some cases, SBPs are 
linked in a single polypeptide with the TMD of the transporter (Eitinger et al., 2010; ter Beek et 
al., 2014).  
Despite their little sequence conservation, SBPs display a similar folding pattern composed 
of two symmetrical lobes or domains (termed N- and C-lobe according to the protein’s termini). 
Each lobe is composed of an alpha-beta fold consisting of pleated β-sheets surrounded by α-
helices and connected by loops, but the number and order of β-strands vary from lobe to lobe. 
They are connected by a hinge region and the substrate binding site is located in a cleft 
between the two lobes (Davidson et al., 2008; Eitinger et al., 2010). 
In the absence of a ligand, the two lobes exist predominantly in an open conformation, but 
upon substrate binding, the molecule occupies the cleft and induces the lobes to rotate towards 
each other and close (the “Venus fly trap” model). In this new conformation, the SBP is able to 
interact with the appropriate transporter, with each lobe interacting with one of the TMDs 
(Higgins, 1992; Davidson et al., 2008; ter Beek et al., 2014). 
These domains bind their substrates with high affinities, in the range of 0.01 to 1μM. This 
high-affinity binding is responsible for the capture and accumulation of substrate in the vicinity of 
the transporter at submicromolar concentrations (cells can concentrate nutrients up to 106-fold). 
However, SBPs are still essential for transport even at high substrate concentrations, as 
demonstrated by deletion of the gene encoding the maltose-SBP in E. coli. So they probably 
also play an important functional role in the catalytic cycle of the transporter. Substrate 
specificity is achieved mostly by differential H-bonding (Davidson et al., 2008; Eitinger et al., 
2010).  
ABC importers are specific for a single substrate or for a family of structurally related 
substrates, such as maltose and maltodextrins. However, some are more versatile, handling 
structurally unrelated substrates. This is possible either because a single SBP can recognize 
various substrates, as illustrated by the MalEFG1 transport system of Thermus thermophiles 
HB27 (which recognizes maltose, trehalose, sucrose and palatinose), or the importer is able to 
connect to multiple SBPs with different binding specificities, as illustrated by the His/Lys/Arg 
transport system in Enterobacteriaceae (Higgins and Ames, 1981; Silva et al., 2005; Davidson 
et al., 2008; ter Beek et al., 2014). 
 
 




The Transmembrane Domains (TMD) 
The TMDs are integrated in the membrane forming a channel, located at the interface 
between the two domains, which is alternately accessible from the cis-side and trans-side of the 
membrane. The two domains of one transport system can be either homodimers or 
heterodimers (e.g., MalF and MalG of the maltose transporter MalEFGK2 share only 13% 
sequence identity but are structurally related; ter Beek et al., 2014). 
The TMDs are highly hydrophobic and each one usually consists of six α-helices that span 
the membrane with the N- and C-termini on the cis-side, however this number varies from 
transporter to transporter ranging from five to eight. Probably all the transporters maintain a 
core number of α-helices essential for functionality and the remaining exist simply to facilitate 
correct folding, packing, and orientation within the membrane. The transmembrane domains 
contacts the other domains (SBPs and NBDs) through intra- and extracellular protrusions that 
connect the transmembrane segments (Higgins, 1992; Eitinger et al., 2010). 
Indeed, in one of those intracellular protrusions there is an α-helix that plays an essential 
role in the interaction between the TMDs and the NBDs. This helix is called the coupling helix, 
existing in each TMD, and is a conserved element located between the transmembrane helices 
3 and 4 that fits into a groove of a NBD monomer (Figure 1.3A; Higgins, 2001; Eitinger et al., 
2010; ter Beek et al., 2014). 
The coupling helices are characterized by a conserved sequence of amino acids: EAA-X3-
G-X9-I-X-LP (where X is any amino acid). In the NBD, the region that interacts with the coupling 
helices is the Q-loop and the groove in which the helix fits is located at the interface between 
the helical subdomain and the RecA-like subdomain. However, other interactions are being 
discovered. In the MalFGK2 maltose transporter of E. coli it was found that the C-terminal 
segment of MalG (one of the TMDs) is partially inserted between the two MalK (NBDs), as 









Figure 1.3 – TMDs and MalK interactions. A) Docking of the coupling helix into a surface cleft of 
MalK. The EAA loops of MalF and MalG are compared by superposition of the two MalK subunits. The 
MalK dimer is also shown as a transparent surface model. WA - Walker A motif; WB - Walker B motif. B) 
Insertion of the MalG C-terminal segment into the MalK dimer interface. The two MalK subunits are 
represented as a transparent surface model except for the interacting Q-loops, which are shown in stick 
model. Hydrogen bonds and salt bridges are indicated by black dashed lines (adapted from Oldham et al., 
2007). 
 
The Nucleotide Binding Domains (NBD) 
The NBDs can be considered as the ‘motor domains’ of ABC transporters. These domains 
are a subgroup of the diverse superfamily of P-loop NTPases and depend on magnesium ions 
for catalysis. Each NBD has a core of ~200 amino acids with a highly conserved architecture 
and sequence identity, varying between 30 and 50% identity depending on the transporters 
being compared. These proteins consist of two subdomains: the larger RecA-like domain, which 
is also found in other P-loop ATPases, and a structurally more diverse α-helical domain, which 
is unique to ABC transporters. The two subdomains are interconnected by two flexible loop 
regions (Higgins, 1992; Eitinger et al., 2010; ter Beek et al., 2014). 
 
NBDs have a specific set of six highly conserved motifs: 
1) The P-loop or Walker A motif (GXXGXGK(S/T)) forms a loop structure, containing a highly 
conserved lysine residue that binds to the β- and γ-phosphate of ATP. 
2) The Walker B motif (φφφφDE, where φ is a hydrophobic amino acid) is involved in the 
coordination of Mg2+ via the conserved aspartate residue and polarizes the attacking water 
molecule via the glutamic acid.  
 




3) The D-loop helps to form the ATP hydrolysis site. 
4) The H-loop (name that derives from the highly conserved histidine residue present in this 
motif) assists with the positioning of the attacking water and Mg2+. 
5) The Q-loop has approximately eight residues with a conserved glutamine residue that 
binds to Mg2+. Its involved in the interaction between the TMDs and NBDs. 
6) The LSGGQ signature motif is located in the α-helical subdomain and is exclusive to the 
ATPase from the ABC superfamily. (Figure 1.4; Oldham et al., 2007; Eitinger et al., 2010; 
ter Beek et al., 2014). 
 
In the assembled transporter, NBDs are present as a dimer but can adopt different 
conformations: packed tightly against each other (closed conformation) or partially dissociated 
(open conformation). ATP binding promotes the closure in a “tweezer-like” fashion with the ATP 
bound between the Walker A residues of one monomer and the Signature motif of the other 
monomer. In this state ATP hydrolysis occurs and the consequent release of Pi destabilizes the 
dimer which reopens. When the NBD dimer is bound to ADP it resides in a semi-open state 
which presumably returns to the open apo-state after the dissociation of ADP. These 
conformational changes promotes the alternating access of the translocation pathway to the two 
sides of the membrane, through the interactions of the Q-loops of the NBDs and the coupling 
helixes of the TMDs (Rees et al., 2009; Eitinger et al., 2010; ter Beek et al., 2014). These 
interactions must be specific as the ATP-binding domain from one transporter cannot normally 
replace that of another (Higgins, 1992). 
Additionally, the NBDs activity may be regulated through protein interactions with the C-
Terminal domain (C-Terminal Regulatory Domain) which has a common tertiary fold. The 
maltose/maltodextrins transport system can be regulated at the NBD (MalK) activity level. The 
C-terminal domain of MalK can interact with EIIAglc (involved in the carbon catabolite repression 
in E. coli) and MalT (mal regulon activator) (Biemans-Oldehinkel et al., 2006; Cui and Davidson, 
2011). 
When glucose is present in the cell, MalK is inactived by EIIAglc (unphosphorylated form) 
binding to the C-Terminal. This regulatory process determines the hierarchy of sugar utilization 
and is known as inducer exclusion mechanism. On the other hand, MalK can inactivate mal 
genes expression through binding to the maltotriose binding site of MalT. Binding of maltotriose 
to MalT is essential for oligomerization and consequent DNA binding. This MalT inactivation 
only occurs when there is no transport activity. Finally, the C-Terminal domain may also be 
involved in a process called trans-inhibition. The accumulation of substrate in the cytoplasm can 
decrease transport activity and this is called trans-inhibition. In some ATPases, the regulatory 
domain forms substrate-binding pockets where the substrate can bind to the dimer locking the 
 








Figure 1.4 – Conserved motifs in the NBDs domain and subdomains. The RecA-like domain 
comprises the Walker A and B motifs responsible for binding ATP, the H-loop which has a highly 
conserved residue that allows contact with γ-phosphate of ATP and the D loop that contacts the Walker A 
of the other monomer. In the Helical subdomain is localized the signature  motif,  which  is  unique  to  ABC  
ATPases and also  contacts  ATP. The Q-loop, like the H-loop, has a highly conserved residue and is 
responsible for the formation and disruption of the catalytic site. This motif is present in one of the 
connective loops. The C-Terminal regulatory domain is not shown (adapted from ter Beek et al., 2014). 
 
Multitask ATPases 
Initially it was thought that each transporter complex had an exclusive ATPase protein, with 
each TMDs couple having a unique interaction site only recognised by one ATPase in the cell 
(Schneider and Hunke, 1998). However with the increase of knowledge about these transport 
systems new observations lay some doubts on this idea. 
In S. mutans, the MsmEFGK system is a multiple sugar transporter responsible for the 
transport of raffinose, melibiose, stachyose, isomaltose, and isomaltotriose (referred in the SBP 
subsection). There is also another ABC transporter named MalXFGK which is responsible for 
the uptake of maltodextrins. Both transport systems have their own ATPases (MsmK and MalK) 
to energize the translocation process, which are encoded in the same operon as the other 
protein domains of the respective transport system. Surprisingly it was shown that both 
ATPases can interact with either their own or the alternative transporter complex (Russell et al., 
1992; Webb et al., 2008). 
Streptomyces species have an ATPase named MsiK, which is involved in oligosaccharide 
uptake systems. MsiK was shown to energize the transport systems responsible for the uptake 
of cellobiose, xylobiose and maltose in Streptomyces lividans (Hurtubise et al., 1995; Kampers 
et al., 1997), while in Streptomyces reticuli, MsiK energizes the trehalose uptake system 
 




(Schlösser, 2000). In Streptomyces coelicolor beside being required for the transport of N,N’-
diacetylchitobiose, some of the data suggest that MsiK plays a role in the utilization of the 
disaccharides maltose and cellobiose (Saito et al., 2008). 
In the Gram-positive B. subtilis an in silico analysis identified at least 78 ABC transporters 
based on the identification of 86 NBDs in 78 proteins, 103 TMDs proteins, and 37 SBP proteins. 
From these 78 ABC systems at least 10 are predicted to be involved in sugar uptake, however 8 
of these systems do not have a NBD protein being coded in the same operon. The B. subtilis 
genome encodes two potential ATPases capable of energizing the uptake of sugars: msmX and 
yurJ (Quentin et al., 1999; Ferreira and de Sá-Nogueira, 2010). Recent work, demonstrated that 
MsmX interacts with several of these 8 distinct ABC sugar importers orphans of an NBD, thus 
energizing the transport of several sugar oligomers: maltodextrins (Schönert et al., 2006), 
arabinooligosaccharides (Ferreira and de Sá-Nogueira, 2010), galactooligosaccharides, 
galaturonic acid oligomers and rhamnogalacturonic acid  (Ferreira and de Sá-Nogueira, 
unpublished data). Thus, unlike other NBDs, MsmX was shown to be multitask serving as 
energy-generating component to several sugar importers (Figure 1.5). 
This type of multitask ATPases was also observed in the pathogenic species 
Streptococcus pneumoniae. It was demonstrated that the MsmK ATPase, from S. pneumoniae 
TIGR4, is the NBD protein partner for the raffinose, maltotetraose, fructooligosaccharides and 
sialic acid ABC importer systems. Thus, MsmK has been show to energize four of the six 
Carbohydrate Uptake Transporter-1 (CUT1) family transporters found in this species (Marion et 
al., 2011; Linke et al., 2013). 
These evidences demonstrate that bacteria evolved towards the sharing of energy-
generating components between ABC importers, from the same organism, involved in 
carbohydrate utilization. Whether this evolved for genome minimization or transport regulation 
remains unknown (Buckwalter and King, 2012). Therefore a better knowledge about these 
multitask ATPases may have an important impact in therapy development for pathogenic 
bacteria.  
First of all, carbohydrate utilization is crucial for the survival of many microorganisms. If the 
utilization of these substrates is impaired most probably it will be possible to prevent the 
proliferation of pathogenic organisms in certain specific conditions (Buckwalter and King, 2012). 
One example is MsmK which has been linked to airway colonization maintenance (Marion et al., 
2011). Secondly, biofilm formation, which confers resistance to antibiotics, has been shown to 
be linked to carbohydrate metabolism. Recently it was demonstrated that B. subtilis biofilm 
formation was induced by polysaccharides like pectin, arabinogalactan and xylan (Beauregard 
et al., 2013). Also galactan consumption and galactose metabolism play an important role in 
biofilm production (Chai et al., 2012). Furthermore, the ABC importers are a mechanism of 
transport exclusive to prokaryotes, thus these ATPases may represent potential targets for 
therapy since they do not exist in human cells. 
 





Figure 1.5 - MsmX-dependent ABC importers in B. subtilis. The ABC-type importer AraNPQ is 
involved in the uptake of α-1,5-arabinooligosaccharides (arabinotriose, arabinotetraose and some 
arabinobiose). The ABC-type importer MdxEFG is involved in the uptake of maltodextrins. The 
CycB/GanPQ ABC-type importer is responsible for the uptake of galactooligosaccharides. The YesOPQ 
and YtcQ/YesPQ transport systems are involved in the uptake of galacturonic acid oligomers and/or 





1.3. Scope of the Thesis 
In this work we will show that B. subtilis can be used as a model organism to study these 
multitask ATPases from other Gram-positive pathogenic species, facilitating the study of these 
proteins since B. subtilis is a well-known organism and easily manipulated genetically. For this 
purpose, we demonstrate that these multitask ATPases from other species are able to replace 
the B. subtilis MsmX function in the cell. Furthermore, we show that MsmX is in fact a protein 
capable to hydrolize ATP and that amino acid K43 is essential for MsmX functionality both in 










Development of an in vivo system to test the 















2. Development of an in vivo system to test the functionality of 
msmX Alleles and MsmX homologs 
2.1 Introduction 
In the Gram-positive model organism Bacillus subtilis the MsmX ATPase was shown to 
energize multiple ABC carbohydrate importers. One of those importers is the AraNPQ transport 
system, encoded by the ara operon, which is responsible for the uptake of arabino-
oligosaccharides and that requires the presence of MsmX for energizing the system (Ferreira 
and de Sá-Nogueira, 2010).  
The gene encoding MsmX seems to belong to an operon located at 340ºC where it is co-
transcribed with yxkF, a putative PucR regulatory protein (http://www.ncbi.nlm.nih.gov; Kunst et 
al., 1997). However monocistronic messages were detected in both rich and minimal medium 
(Yoshida et al., 2000). An in silico survey identified MsmX homologs in several pathogenic 
bacteria. 
The aim of the work presented in this chapter is to develop an in vivo system in order to 
test if those homologs are capable of playing the role of MsmX in the cell, hence demonstrating 
that the B. subtilis multitask ATPase can be used as a model to study those proteins. Genes 
from Bacillus thuringiensis, Staphylococcus aureus and Streptococcus pneumoniae were 
introduced in a B. subtilis msmX-null mutant genome under the control of an inducible promoter. 
The capacity of each gene to complement MsmX deficiency was evaluated through their ability 
to energize the AraNPQ system in B. subtilis. We show that these proteins from different 
pathogenic bacteria are able to substitute MsmX and energize the B. subtilis transporter. 
Moreover, we showed that modifications in the N- and C-terminal amino acids of MsmX do not 























2.2 Materials and Methods 
Substrates 
1,5-α-L-Arabinotriose (sugar beet, purity 95%) was purchased from Megazyme 
International Ireland Ltd., arabinose and glucose from Sigma-Aldrich Co. 
Bioinformatic Analysis 
For the identification of MsmX homologs in other Gram-positive bacteria bioinformatics 
tools were used. BLASTp algorithm was used to compare MsmX amino acid sequence with the 
sequence database from the National Center for Biotechnology Information at the National 
Institutes of Health, Bethesda, Maryland (http://www.ncbi.nlm.nih.gov). Proteins with an identity 
superior to 60% were considered as targets. An amino acid sequences alignment was made 
using the multiple sequence alignment algorithm ClustalW2 (EMBL-EBI). Translation rates were 
calculated using RBS Calculatorv2.0 created by Salis Lab, Pennsylvania State University (Salis 
et al., 2009; Salis, 2011). 
DNA manipulation and sequencing 
Routine DNA manipulations were performed as described by Sambrook et al. (1989). All 
restriction enzymes were purchased from Thermo Fisher Scientific Inc. and used according to 
the manufacturers’ recommendations. PCR amplifications were carried out using Phusion® 
High-Fidelity DNA Polymerase (Thermo Fisher Scientific Inc.). DNA from agarose gels and PCR 
products were purified with the illustraTM GFXTM PCR DNA and Gel Band Purification kit (GE 
Healthcare). All DNA ligations were performed using T4 DNA Ligase (Thermo Fisher Scientific 
Inc.). Plasmids were purified using the QIAGEN® Plasmid Midi kit (Qiagen) or NZYMiniprep kit 
(NZYTech, Lda.). DNA sequencing was performed with the ABI PRISM BigDye® Terminator 
Cycle Sequencing Kit (Applied Biosystems). The sequencing reaction was purified by gel 
filtration and resolved in an ABI 3730XL sequencer. 
Construction of plasmids and strains 
Plasmid pAM4 was obtained by amplification of the msmX gene from chromosomal DNA of 
the wild-type strain B. subtilis 168T+, with the oligonucleotides ARA741 and ARA742, which 
 




contain unique restriction sites SalI and SphI, and the resulting fragment (1224bp) inserted 
between the SalI and SphI sites of pDR111 (gift from David Rudner, Harvard University). pAM5 
was obtained by amplification of the HD73_4301 gene, from chromosomal DNA of strain B. 
thuringiensis serovar kurstaki str. HD73 (Bacillus Genetic Stock Center, BGSC, Ohio State 
University), with the oligonucleotides ARA744 and ARA745, bearing unique restriction sites SalI 
and SphI, and subsequent cloning of this fragment (1272bp) into pDR111 digested with SalI and 
SphI. The amplification of the ugpC gene, from chromosomal DNA of the pathogenic strain 
Staphylococcus aureus subsp. aureus ST398 (a gift from Hermínia de Lencastre, ITQB, 
Universidade Nova de Lisboa), using oligonucleotides ARA746 and ARA747, which contain 
unique restriction sites SalI and SphI, and cloning this fragment (1215bp) into pDR111 SalI-
SphI, yielded plasmid pAM6. The amplification of the msmK gene, from chromosomal DNA of 
strain Streptococcus pneumoniae TIGR4 (a gift from Hermínia de Lencastre, ITQB, 
Universidade Nova de Lisboa), with the oligonucleotides ARA748 and ARA749, harbouring 
unique restriction sites SalI and SphI, and subsequent cloning of this fragment (1295bp) 
between the SalI and SphI sites of pDR111, yielded plasmid pAM7. pAM9 and pAM10 were 
obtained by site-directed mutagenesis and their construction is described below. Plasmid 
pAM12 was obtained by amplification of the msmX sequence using pAM9 as template with the 
oligonucleotides ARA741 and ARA742, which contain unique restriction sites SalI and SphI, and 
then the resulting fragment (1224bp) was inserted between the SalI and SphI sites of pDR111. 
Plasmids and oligonucleotides used in this work are listed in Table 2.1 and 2.2, respectively. 
 
 
Table 2.1 - List of plasmids used or constructed during the course of this work. 




Derivative of the Pspac(hy) plasmid pJQ43; contains an additional lacO 
binding site 
David Rudner 
pAM4 PDR111 derivate, with msmX under the control of Pspank(hy) This work* 
pAM5 PDR111 derivate, with HD73_4301 under the control of Pspank(hy) This work* 
pAM6 PDR111 derivate, with ugpC under the control of Pspank(hy) This work* 
pAM7 PDR111 derivate, with msmK under the control of Pspank(hy) This work* 
pMJ1 pBluescript II KS(+)-based plasmid harboring the msmX coding region 
Ferreira and de Sá-
Nogueira, 2010 
pAM9 pMJ1 derivate, with a new BglII restriction site in msmX coding region This work* 
pAM10 pAM10 derivate, with a new NheI restriction site in msmX coding region This work* 
pAM12 PDR111 derivate, with msmX  from pAM10 under the control of Pspank(hy) This work* 
* See Appendices from to 6.2 to 6.7 and 6.9. 



















a Sequence orientation is 5’→3’. Restriction sites are underlined. 
 
 
Plasmids pDR111, pAM4, pAM5, pAM6, and pAM7, were used to transform the IQB495 
strain, according to the method described by Anagnostopoulos and Spizizen, 1961, resulting in 
strains IQB672 (pDR111), IQB673 (pAM4), IQB674 (pAM7), IQB677 (pAM5) and IQB678 
(pAM6) strains (Table 2.3). The transformants were screened for amyE- phenotype. The amyE 
phenotype was tested on plates of solid LB medium containing 1% (w/v) potato starch; after 
overnight incubation, plates were flooded with a solution of 0.5% (w/v) I2–5.0% (w/v) KI for 
detection of starch hydrolysis.  
 
 
Table 2.3 - List of B. subtilis strains used or constructed during the course of this work. 
Strain Relevant genotype Sources or Referencea 
168T+ Prototroph F. E. Young 
IQB495 ΔmsmX::cat 
Ferreira and de Sá-Nogueira, 
2010 
IQB672 ΔmsmX::cat ΔamyE::Pspank(hy) pDR111 → IQB495 
IQB673 ΔmsmX::cat ΔamyE::Pspank(hy)-msmX pAM4 → IQB495 




pAM12 → IQB495 
IQB677 ΔmsmX::cat ΔamyE::Pspank(hy)-HD73_4301 pAM5 → IQB495 
IQB678 ΔmsmX::cat ΔamyE::Pspank(hy)-ugpC pAM6 → IQB495 
a The arrows indicate transformation and point from donor DNA to recipient strain 
 





Vector pMJ1 was used as template for site-directed mutagenesis experiments using the 
mutagenic oligonucleotides ARA769 and ARA770. This pair of primers allowed the generation 
of an unique BglII restriction site in the 4th nucleotide, downstream from the start codon This 
originated a mutation in the residue at position 3 (Glu to Ser) in the resulting plasmid pAM9. 
Afterwards, pAM9 was used as a template with mutagenic oligonucleotides ARA771 and 
ARA772, which created an unique NheI restriction site in the 11th nucleotide, upstream from the 
stop codon. The resulting plasmid pAM10 contains a mutation in the residue at position 364 (Ile 
to Ser). For both site-directed mutagenesis experiments, a polymerase chain reaction was 
carried on using 1x Phusion® GC Buffer (Thermo Fisher Scientific Inc.), 0.2 μM primers, 200 
μM dNTPs, 3% DMSO, 0.8 ng/μL of Template DNA (first pMJ1 and in the second pAM9) and 
0.02 U/μL of Phusion® High-Fidelity DNA Polymerase in a total volume of  50 μL. The PCR 
product was digested with 10 U of DpnI, at 37 ºC, overnight. Both mutations were confirmed by 
DNA sequencing. 
Growth conditions 
E. coli XL1Blue (Strategene) was used as host for the construction of all pDR111 derives 
and E. coli DH5α (Gibco-BRL) used for pMJ1 derives. All E. coli strains were grown in liquid 
Luria-Bertani (LB) medium (Miller, 1972) and on LB solidified with 1.6% (w/v) agar, ampicillin 
(100 μg/mL) and/or Tetracycline (12 μg/mL) were added as required. B. subtilis was grown in 
liquid LB medium, LB medium solidified with 1.6% (w/v) agar or SP medium (Martin et al., 1987) 
with chloramphenicol (5 μg/mL) and spectinomycin (50 μg/mL) being added as required. Growth 
kinetics parameters of the wild-type and mutant B. subtilis strains were determined in liquid 
minimal medium. B. subtilis strains 168T+, IQB672, IQB673, IQB674, IQB676, IQB677 and 
IQB678 were grown overnight (37 ºC, 150 rpm), from freshly streaked colonies, in C minimal 
medium (Pascal et al., 1971) supplemented with L-tryptophan (100 μg/mL), potassium 
glutamate (8 μg/mL) and potassium succinate (6 μg/mL) (CSK medium; Debarbouille et. al, 
1990). The cell cultures were washed and resuspended, to an initial OD600nm of 0.05, in 1.5 mL 
of CSK medium without potassium succinate and supplemented with different carbon and 
energy sources (glucose, arabinose and arabinotriose) at a final concentration of 0.1% (w/v) 
and IPTG (expression inducer) at 1 mM was added when appropriated. The  cultures were 
grown in sterile 50 mL Falcon tubes (Sarstedt), incubated at 37 ºC and 150 rpm in an OLS200 
orbital/linear shaking bath (Grant Instruments) and the OD600nm periodically read in an Ultrospec 
2100 pro UV/Visible Spectrophotometer (GE Healthcare Life Sciences). 
 





2.3 Results and Discussion 
In silico Survey 
An in silico survey was performed for the identification of MsmX homologs, in other Gram-
positive bacteria, using BLASTp tool. From this analysis Bacillus thuringiensis, Bacillus cereus, 
Staphylococcus aureus and Streptococcus pneumoniae proteins were selected (Table 2.4). The 
proteins from B. thuringiensis and B. cereus have the higher identity (74%) while UgpC from S. 
aureus exhibits a homology of 66%. MsmK from S. pneumoniae possess the lower homology 
(64%). Although we identified proteins from B. thuringiensis and B. cereus in these studies we 
only used the first because they both have identical amino acid sequence. A multiple alignment 
of the proteins primary sequence was performed using ClustalW2 and is shown in the Appendix 
6.11. The genomic context of each gene selected for study is displayed in Appendices 6.36, 




Table 2.4 – MsmX homologs selected. List of MsmX homologs selected for this work, with 
respective NCBI Database Reference and identity with MsmX. 




Bacillus thuringiensis serovar 
kurstaki str. HD73 
HD73_4301 YP_007423400.1 366 271 (74%) 
Bacillus cereus ATCC 14579 BC4016 NP_833734.1 366 271 (74%) 




YP_005733033.1 365 240 (66%) 
Streptococcus pneumoniae TIGR4 
msmK 
(or SP_1580) 
NP_346026.1 375 241 (64%) 
 
Development of a Genetic System for Complementation Analysis 
In order to test if other multitask ATPases (MsmX homologs), found in pathogenic species, 
are able to play the roles of MsmX in the cell, we developed an in vivo system for their 
expression in a B. subtilis msmX-null mutant (IQB495). For this, we placed the genes under the 
control of an inducible promoter and used an integrative B. subtilis vector. 
The incorporation of the genes in the chromosome guarantees no variations in the number 
of copies present in the cell during the experiments and for comparison analysis. The use of an 
inducible promoter allows a comparable and controlled expression of the different genes. The 
 




capability of the other ATPases to fully (or partially) complement the msmX absence was 
evaluated using the AraNPQ transport system, which cannot transport arabinotriose in the 
absence of MsmX. Determination of the growth kinetics parameters of the distinct strains, 
bearing the genes encoding each one of the ATPases selected, using arabinotriose as the sole 
carbon and energy source was the physiological parameter used in order to evaluate the 
functionality of each protein in the cell. 
The integrative vector chosen to construct this system was pDR111 (Appendix 6.1) that 
enables gene expression from a modified version of the Pspac promoter, the Phyper-spank 
promoter (Pspank(hy)), which is stronger and bears an additional lacO binding site to achieve a 
better repression in the absence of inducer (Quisel et al., 2001; Britton et al., 2002). Gene 
expression can be induced with IPTG, a compound that mimics allolactose but is not 
hydrolysable, therefore maintaining sustainable levels of expression along time. The plasmid 
possesses two amyE gene fragments for integration at the amyE locus of the B. subtilis 
chromosome. However this plasmid does not have any ribosomal binding site (RBS) thus the 
genes were cloned into this vector with their own RBS and for practical reasons also their 
terminator. 
A schematic illustration of the in vivo system developed and the strains constructed for this 
work are represented in Figure 2.1 and 2.2, respectively.  
 
 
Figure 2.1 – Schematic illustration of the in vivo system developed. The amyE locus at 28º is 
represented (top left) with the genes introduced by a double-recombination event with pDR111 derivatives: 
a lacI copy (red arrow), a spectinomycin resistance cassette (blue arrow), both from pDR111, a copy of the 
msmX gene, or homolog (green arrow) and the amyE gene fragments (yellow arrows). At 340º, is shown 
the yxkF-msmX operon with the msmX inactivated by an insertion-deletion mutation with a 
chloramphenicol resistance cassette (cat). 
 






Figure 2.2 – Schematic representation of the amyE locus and the yxkf-msmX operon in the 
chromosome of several B. subtilis strains used in this work (not drawn to scale). 
 
MsmX Functional Studies  
First the functionality of the system was tested using the msmX under the control of 
Pspank(hy) in a msmX-null mutant genetic background (strain IQB673; Figure 2.2). A negative 
control (strain IQB492; Figure 2.2) was constructed by transformation of strain IQB495, msmX-
null mutant genetic background, with plasmid pDR111. The wild-type strain 168T+ was used as 
positive control. Growth kinetics parameters of the three strains in minimal medium using 
arabinotriose (MsmX dependent uptake), glucose and arabinose (both MsmX independent 
uptake) as the sole carbon and energy source, were determined and the results are 
summarized in Table 2.5. 
The doubling time of strains IQB672 and IQB673 in a medium supplemented with glucose 
and arabinose are similar to those of the wild-type strain 168T+ and the presence of IPTG did 
 




not cause any variation in these values. Variations were not expected since both saccharides 
are transported by systems that are not dependent of MsmX for functionality. Moreover, the 
addition of IPTG does not have any toxic effect on the cells, and the presence of a copy of the 
lacI gene and the spectinomycin resistance gene do not affect growth in these conditions. 
 
 
Table 2.5 – Growth of different strains 168T+, IQB672 and IQB673 in the presence of several 
saccharides as sole carbon/energy. 
Carbon Source 
Doubling Time (minutes)* 
168T+                             
(wild-type) 
IQB672                                                  
(ΔmsmX::cat 
ΔamyE::Pspank(hy)) 
IQB673                                               
(ΔmsmX::cat 
ΔamyE::Pspank(hy)-msmX) 
Glucose 0.1% 60.65±0.58 58.58±1.45 58.38±2.24 
Glucose 0.1% + IPTG 1mM - 59.81±0.68 59.07±1.97 
Arabinose 0.1% 78.75±3.09 79.76±1.64 78.47±3.47 
Arabinose 0.1% + IPTG 1mM - 76.61±2.94 77.53±2.95 
Arabinotriose 0.1% 114.25±3.70 No Growth No Growth 
Arabinotriose 0.1% + IPTG 1mM - No Growth 107.60±3.85 
* Cells were grown in CSK minimal medium (see Materials and Methods). Growth kinetics parameters 
were determined and the results represent the average of three independent experiments, except the 
glucose and arabinose growths for strains IQB672 and IQB673 without IPTG, which were performed only 







Figure 2.3 - Growth of B. subtilis 168T+ (wild-type) in CSK medium using glucose, arabinose 























The results obtained using only arabinotriose as a carbon/energy source display different 
behaviours. As expected, the negative control, strain IQB672, was not able to use the 
saccharide to support growth, even in the presence of IPTG (Table 2.5 and Figure 2.4). In this 
strain, there is no MsmX present in the cells to energize the AraNPQ transport system. Strain 
IQB673 was also not able to grow in the presence of arabinotriose, however when IPTG was 
added to the medium, the wild-type phenotype was restored since the doubling time is similar to 
that displayed by strain 168T+ (Table 2.5 and Figure 2.5). 
These results show that IPTG induces expression of the msmX gene present at the amyE 
locus, which allows the cell to transport arabinotriose from the medium to the cytoplasm through 
the AraNPQ transporter. 
Furthermore, when we compare the doubling time of strains 168T+ and IQB673 with 
arabinotriose the results are very similar (considering the deviations; Table 2.5). Nonetheless, a 
very slight decrease in IQB673 doubling time is observed and this variation could be due to a 
small increase in the amount of MsmX present in the cell, due to the fact that the copy of msmX 
present in trans is being transcribed from a different promoter. This observation however, is not 
relevant for the purpose of this genetic system, which is to test the functionality of MsmX 
homologs, or different alleles of msmX bearing mutations, because kinetics of growth will be 




Figure 2.4 - Growth of IQB672 (ΔmsmX::cat ΔamyE::pSpank(hy)) in CSK medium using 
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Figure 2.5 - Growth of IQB673 (ΔmsmX::cat ΔamyE::pSpank(hy)-msmX) in CSK medium using 
glucose, arabinose and arabinotriose as the sole carbon and energy source. 
 
In sum, the results obtained indicate that  the expression of msmX in trans using the 
system developed does not affect the bacteria phenotype in the presence of arabinotriose i.e. 
we may conclude that using this system the intracellular concentration of MsmX is sufficient to 
energize the AraNPQ transporter as observed in the wild-type strain. Cells expressing msmX in 
trans, under the control of the inducible Pspank(hy) promoter, and the wild-type cells expressing 
the msmX in the original locus, under the control of its own promoter, display a similar 
phenotype under the tested conditions. Thus, the genetic system constructed is suitable for 
studying the effect of mutations in the msmX allele and to test the functionality of MsmX 
homologs in B. subtilis. 
Functional Analysis of MsmX Homologs 
As described above, we identified MsmX homologs in several pathogenic species and 
select proteins from B. thuringiensis, S. aureus and S. pneumoniae. Using the system 
developed, we tested if the homologs chosen were able to complement MsmX absence in B. 
subtilis. 
The different genes were placed under the control of the inducible Pspank(hy) promoter at 
the amyE locus and resulted in the construction of strains IQB674 (msmK gene from S. 
pneumoniae), IQB677 (HD73_4301 from B. thuringiensis) and IQB678 (ugpC from S. aureus) is 
depicted in Figure 2.2. Growth kinetics parameters of the three strains in minimal medium using 
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uptake) as the sole carbon and energy source, were determined and the results are 
summarized in Table 2.6. 
Table 2.6 - Growth of different B. subtilis strains in the presence of several saccharides as sole 
carbon/energy. 
Carbon Source 
Doubling Time (minutes)* 




IQB674                                           
(ΔmsmX::cat 
ΔamyE::Pspank(hy)-
msmK                   
[S. pneumonia]) 
IQB677                                                 
(ΔmsmX::cat 
ΔamyE::Pspank(hy)-
HD73_4301          
[B. thuringiensis]) 





Glucose 0.1% 58.38±2.24 59.17±1.81 59.98±1.18 59.38±0.50 
Glucose 0.1% + 
IPTG 1mM 
59.07±1.97 59.88±2.52 60.62±0.71 61.49±2.13 
Arabinose 0.1% 78.47±3.47 80.97±3.81 79.01±0.59 79.98±1.65 
Arabinose 0.1% + 
IPTG 1mM 
77.53±2.95 81.40±2.20 77.22±1.98 81.40±2.20 
Arabinotriose 0.1% No Growth 260.87±11.18 No Growth No Growth 
Arabinotriose 0.1% 
+ IPTG 1mM 
107.60±3.85 226.05±9.55 141.18±3.76 205.47±8.28 
* Cells were grown in CSK minimal medium (see Materials and Methods). Growth kinetics parameters 
were determined and the results represent the average of three independent experiments, except the 
glucose and arabinose growths without IPTG, which were performed only twice (see Annexes for the 
complete data used in the determination of doubling time). IQB673 results are the same presented in table 




The doubling time of strains IQB674, IQB677, and IQB678, in a medium supplemented 
with glucose and arabinose are similar to those of the wild-type strain 168T+ and the presence 
of IPTG did not cause any variation in these values, as previously observed with strain IQB673 
(Table 2.5 and Table 2.6). 
Regarding the growth with arabinotriose in inducible conditions, plus IPTG, all the three 
strains were able to growth in the presence of arabinotriose as the sole carbon and energy 
source. This phenotype is not observed in the absence of IPTG in strains IQB677, and IQB678 
(Table 2.6 and Figures 2.7 and 2.8), unexpectedly strain IQB674 was able to growth in the 
presence of arabinotriose even in the absence of IPTG (Table 2.6 and Figure 2.6). A closer look 
to the sequence of msmK amplified from S. pneumonia and cloned in pDR111 revealed that in 
addition to the RBS we also cloned a putative msmK promoter (PmsmK). Thus, transcription of 
msmK is initiated at this promoter and is not subjected to regulation by LacI. Interestingly, the 
growth of strain IQB674 in arabinotriose in the absence of IPTG is slower than that observed in 
the presence of IPTG (a difference of about 34 min), suggesting that in inducing conditions 
transcription of msmK is also driven by the Pspank(hy) promoter. 
 





Figure 2.6 - Growth of IQB674 (ΔmsmX::cat ΔamyE::pSpank(hy)-msmK) in CSK medium using 
glucose, arabinose and arabinotriose as the sole carbon and energy source. 
 
Figure 2.7 - Growth of IQB677 (ΔmsmX::cat ΔamyE::pSpank(hy)-HD73_4301) in CSK medium 
using glucose, arabinose and arabinotriose as the sole carbon and energy source. 
 
Figure 2.8 - Growth of IQB678 (ΔmsmX::cat ΔamyE::Pspank(hy)-ugpC) in CSK medium using 
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In conclusion these results show that msmK from S. pneumoniae, HD73_4301 from B. 
thuringiensis and ugpC from S. aureus are able to play the role of msmX in energizing the B. 
subtilis AraNPQ transporter, and suggest that MsmK, HD73_4301, and UgpC are able to 
interact with the TMDs from the AraNPQ transporter in the absence of MsmX.  
Nevertheless, the complementation of MsmX deficiency observed is only partial, the 
doubling time, determined in inducing conditions in the presence of arabinotriose in strains 
IQB674 (msmK from S. pneumoniae), IQB677 (HD73_4301 from B. thuringiensis) and IQB678 
(ugpC from S. aureus) increased 2.1-fold, 1.3 fold, and 1.9-fold, respectively, when compared 
with strain IQB673 (msmX from B. subtilis). Comparing these results it seems that the protein 
HD73_4301 from B. thuringiensis is the one who reaches a value closer to full complementation 
of MsmX, while between the other two proteins, UgpC from S. aureus achieves a higher 
complementation degree than MsmK from S. pneumoniae. If we compare the complementation 
degree with protein identity (or homology), or phylogenetic relationship between the species 
used in this work, we can observe some correlation between them. The protein displaying 
higher identity to MsmX is HD73_4301 (74%), which also came from the species 
phylogenetically more close to B. subtilis (same genus), achieved the best complementation 
degree, while the protein with less identity (64%) and also from the further species, in 
phylogenetic terms, attained the worst complementation degree. So it is tempting to speculate 
that a higher protein identity corresponds to a greater ability to play the MsmX role. 
Interestingly, the region of the proteins predicted to interact with the TMDs of AraPQ is 
highly conserved (see Appendix 6.11). However, differences in one or two amino acids near the 
Q-loop, may be sufficient to alter the interaction between the ATPase and one of the TMDs. 
Changes in the electrochemical properties in those positions could affect the interactions 
protein-protein directly or indirectly through interaction with amino acids important for the 
connection with the TMD. These changes could not prevent connection between the two 
proteins, but be enough to slow down the connection and interfering with the uptake rate of 
arabinotriose and, consequently, increasing the doubling time of the strains when using this 
saccharide as carbon/energy source. 
Another aspect that could contribute for these results is possible differences in post-
transcriptional regulation that result in variations in the total NBD protein amount produced in 
each strain. Since each gene was cloned together with its own RBS, and belong to different 
species, we calculated the translation initiation rates for the mRNAs transcribed from each gene 
to estimate the impact of the different RBS in translation initiation. The results obtained are 
summarized in Table 2.7. 
 




Table 2.7 – RBS Calculator algorithm results for each RBS. The translation initiation rate is a 
relative value and is represented in arbitrary units (au). ∆Gtotal – Total energy necessary for translation 
initiation. 
Gene 
Translation Initiation Rate 
(au) 
∆Gtotal (kcal/mol) 
msmX 42339.64 -6.29 
HD73_4301 7519.89 -2.45 
ugpC 229874.35 -10.05 




These results clearly show us that exists differences in the post-transcriptional regulation 
processes, but they do not correlate with the complementation results. In addition to differences 
in the RBS strength, there are other processes that can affect post-transcriptional regulation, 
such as the mRNA stability.  
Since this system was created not only to study these proteins, but also other possible 
multitask ATPases from other bacteria or even from B. subtilis we decided to improve our 
design in order to eliminate those variables, which could influence the results obtained in the 
future experiments. 
Fine-tuning the Genetic System for Functional Analysis 
In order to eliminate transcriptional and the post-transcriptional regulation variables, we 
improved the system’s design. For this purpose we modified the N-terminal and C-terminal of 
MsmX in order to allow the sub-cloning of only the Open Reading Frame (ORF) of the gene to 
be tested.  
The integrative vector was engineered to harbour the RBS and the terminator of B. subtilis 
msmX. The msmX coding sequence was mutated in order to introduce two new unique 
restriction sites at the 5’-end and 3’-end of the gene, one right after the RBS (NheI) and the 
other before the stop codon (BglII). The first one was introduced between the second (Ala) and 
third amino acid (Glu), and led to the transition of the Glu residue to a Ser. The second 
restriction site was introduced between amino acids 363 (Arg) and 364 (Ile), substituting Ile by a 
Ser residue (Figure 2.9). The resulting plasmid pAM12, a pDR111 derivative, containing the 
modified version of msmX, in future studies will be digested with NheI and BglII, which enable 
the removal of the msmX coding region, leaving behind the RBS and terminator, then the ORF 
of the gene object of study will be cloned between those restriction sites.  






Figure 2.9 - Schematic representation of the modifications made in the genetic system. 
The msmX gene is represented by a green arrow and the promoter of the transcriptional unit is depicted by 
a grey arrow and a black box. Above is displayed the sequence of the 5’ and 3’-end of the msmX gene. 
The ribosome-binding site, RBS, is underlined. The nucleotides that were mutated are represented in bold 
and the corresponding modification in the primary sequence of MsmX is depicted above. The new 
restriction sites, NheI (5’-end) and BglII (3’-end), are double underlined. 
 
Although the substitutions were made in the N-terminal and C-terminal MsmX regions, 
which are known not to be important for the function of the NBDs, we tested if the functionality 
and/or capability to interact with the AraNPQ transporter components where not affected. For 
this purpose, we constructed strain IQB676, which harbours the modified version of msmX 
under the control of the inducible Pspank(hy) promoter at the amyE locus, and determined the 
growth kinetic parameters using arabinotriose, glucose and arabinose as the sole carbon and 
energy source. The results are summarized in Table 2.8. 
 
 
Table 2.8 - Growth of IQB673 and IQB676 strains in the presence of several saccharides as 
sole carbon/energy. 
Carbon Source 
Doubling Time (minutes)* 
IQB673                                          
(ΔmsmX::cat    
ΔamyE::Pspank(hy)-msmX) 
IQB676                                          
(ΔmsmX::cat               
ΔamyE::Pspank(hy)-msmX(Glu3Ser, 
Ile364Ser)) 
Glucose 0.1% 58.38±2.24 60.21±0.34 
Glucose 0.1% + IPTG 1mM 59.07±1.97 58.68±1.73 
Arabinose 0.1% 78.47±3.47 76.99±0.28 
Arabinose 0.1% + IPTG 1mM 77.53±2.95 76.80±0.78 
Arabinotriose 0.1% No Growth No Growth 
Arabinotriose 0.1% + IPTG 
1mM 
107.60±3.85 110.27±4.78 
* Cells were grown in CSK minimal medium (see Materials and Methods). Growth Kinetics parameters 
were determined and the results represent the average of three independent experiments, except the 
glucose and arabinose growths without IPTG, which were performed only twice (see Annexes for the 
complete data used in the determination of doubling time). IQB673 results are the same presented in table 
5 and are shown here to facilitate comparison. 
 





Figure 2.10 - Growth of IQB676 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmX(Glu3Ser, Ile364Ser)) 




The doubling time obtained with this strain when in a medium supplemented with glucose 
and arabinose is similar to IQB673 and the presence of IPTG also did not cause any variation in 
these values. In the assays with arabinotriose, but without IPTG added to the medium, there 
was no growth. When IPTG was added the cells were able to grow, with a doubling time similar 
to IQB673. These results indicated that the amino acids substitutions introduced in MsmX do 
not affect neither its functionality nor the interaction with the TMDs, and this improved system 
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Biochemical Characterization of MsmX 
  
 










3. Biochemical Characterization of MsmX 
3.1 Introduction 
The first ATPase with a resolved crystal structure was HisP, from Salmonella typhimurium, 
belonging to the well-characterized histidine ABC transporter HisQMP2 (Hung et al., 1998). 
Since then the crystal structure of several ATPases was solved, such as the MJ0796 and 
MJ1267 proteins from Methanocaldococcus jannaschii (Karpowich et al., 2001; Smith et al., 
2002). Other protein structures were determined with the NBD attached to the TMDs from the 
correspondent transporter like MalK from E. coli, ModC from Archaeoglobus fulgidus and 
Methanosarcina acetivorans (Chen et al., 2003; Hollenstein et al., 2007; Gerber et al., 2008). 
More recently, the structure from ATPases MetNI from E. coli, involved in methionine uptake, 
and LIC12079 from Leptospira spp., involved in manganese utilization, were also determined 
(Rees et al., 2009; Benaroudj et al., 2013). 
Beside crystallography studies, dynamic monomer/dimer equilibrium and ATPase activity 
studies were performed to unravel other important structural information (Horn et al., 2003; 
Verdon et al., 2003; Zoghbi et al., 2012; Benaroudj et al., 2013). Some of these studies 
revealed residues important for ATP hydrolysis like the Glu residue from Walker B motif, the 
second Gly residue from the Signature motif and the conserved Lys from the Walker A motif, 
while the Ser residue from the Signature motif was not essential for the enzymatic activity 
(Verdon et al., 2003; Benaroudj et al., 2013). 
In spite of all these studies, the only well-characterized ATPase of ABC transporters 
involved in the uptake of carbohydrates is MalK from E. coli. To better comprehend the energy-
generating component sharing phenomenon among distinct sugar ABC importers, structural 
and biochemical characterization of multitask ATPases like MsmX must be performed. MsmX is 
highly similar (>40% identity) to MalK from E. coli and MsmK from S. mutans, ATPases of 
transport systems for maltose and multiple sugars, respectively (Ferreira and de Sá-Nogueira, 
2010).  
The aim of the work presented in this chapter was to optimize the production of MsmX in E. 
coli and further purification in order to obtain the necessary amount of protein for functional and 
structure characterization. Additionally functional analysis was performed by site-directed 
mutagenesis. The Lys43 residue of MsmX, predicted to be essential for ATP hydrolysis, was 








3.2 Materials and Methods 
DNA manipulation and sequencing 
Routine DNA manipulations were performed as described by Sambrook et al. (1989). All 
restriction enzymes were purchased from Thermo Fisher Scientific Inc. and used according to 
the manufacturers recommendations. PCR amplifications were carried out using Phusion® 
High-Fidelity DNA Polymerase (Thermo Fisher Scientific Inc.). DNA from agarose gels and PCR 
products were purified with the illustraTM GFXTM PCR DNA and Gel Band Purification kit (GE 
Healthcare). All DNA ligations were performed using T4 DNA Ligase (Thermo Fisher Scientific 
Inc.). Plasmids were purified using the QIAGEN® Plasmid Midi kit (Qiagen) or NZYMiniprep kit 
(NZYTech, Lda.). DNA sequencing was performed with the ABI PRISM BigDye® Terminator 
Cycle Sequencing Kit (Applied Biosystems). The sequencing reaction was purified by gel 
filtration and resolved in an ABI 3730XL sequencer. 
Site-Directed Mutagenesis 
Vectors pMJ22 and pAM4 were used in independent experiments as template for site-
directed mutagenesis using the mutagenic oligonucleotides ARA757 and ARA758 (Table 3.1). 
This pair of primers introduced the mutation of codon AAA (Lys at position 43) to GCA (Ala) in 
the resulting plasmids pAM11 and pAM13, respectively. A polymerase chain reaction was 
carried on using 1x Phusion® GC Buffer (Thermo Fisher Scientific Inc.), 0.2 μM primers, 200 
μM dNTPs, 3% DMSO, 0.6 ng/μL of pMJ22 DNA (or 0.5 ng/μL of pAM4 DNA) and 0.02 U/μL of 
Phusion® High-Fidelity DNA Polymerase in a total volume of 50 μL. The PCR product was 
















Construction of strains 
pAM13 was used to transform IQB495 strain (Table 3.2), according to the method 
described by Anagnostopoulos and Spizizen, 1961, resulting in the IQB675 strain (Table 3.3). 
The transformants were screened for amyE- phenotype. The amyE phenotype was tested in 
plates of solid LB medium containing 1% (w/v) potato starch; after overnight incubation, plates 
were flooded with a solution of 0.5% (w/v) I2–5.0% (w/v) KI for detection of starch hydrolysis. 
 
 
Table 3.2 - List of plasmids used or constructed during the course of this work. 
Plasmids Relevant construction Source or Reference 
pT-GroE 
Vector for expression of GroESL chaperones under the control of T7 
promoter 
(Yasukawa et al., 1995) 
pMJ22 pET30(a)-based vector for the expression of msmX in E. coli 
Ferreira and de Sá-Nogueira, 
unpublished data 
pAM4 PDR111 derivate, with msmX under the control of Pspank(hy) This work* 
pAM11 
pMJ22 derivate with msmX sequence with mutated AAA  
(Lys at position 43) to GCA (Ala) 
This work* 
pAM13 
pAM4 derivate with msmX sequence with mutated AAA  
(Lys at position 43) to GCA (Ala) 
This work* 
* See Appendices 6.2, 6.8 and 6.10. 
 
 
Table 3.3 - List of B. subtilis strains used or constructed during the course of this work. 
Strain Relevant genotype Sources or Referencea 
IQB675 ΔmsmX::cat ΔamyE::pSpank(hy)-msmX(Lys43Ala) pAM13 → IQB495 
a The arrows indicate transformation and point from donor DNA to recipient strain 
 
Growth conditions 
E. coli DH5α (Gibco-BRL) was used as host for routine DNA manipulations for plasmids 
with pET-30(a) backbone and E. coli  BL21 (DE3) pLysS (Studier et al., 1990) and E. coli BL21 
(DE3) (Novagen) were used as hosts for the overproduction of recombinant MsmX and MsmX-
Lys43Ala. E. coli XL1Blue (Strategene) was used for the construction of pDR111 derivatives. All 
 




E. coli strains were grown in liquid Luria-Bertani (LB) medium (Miller, 1972) and on LB solidified 
with 1.6% (w/v) agar, and ampicillin (100 μg/mL), Tetracycline (12 μg/mL), kanamycin (30 
μg/mL) and/or chloramphenicol (25 μg/mL) were added as required. 
B. subtilis was grown in liquid LB medium, LB medium solidified with 1.6% (w/v) agar or SP 
medium (Martin et al., 1987) and chloramphenicol (5 μg/mL) and spectinomycin (50 μg/mL) 
were added as required.  
Growth kinetics parameters were determined in liquid minimal medium. B. subtilis strain 
IQB675 was grown overnight (37 ºC, 150 rpm), from freshly streaked colonies, in C minimal 
medium (Pascal et al., 1971) supplemented with L-tryptophan (100 μg/mL), potassium 
glutamate (8 μg/mL) and potassium succinate (6 μg/mL) (CSK medium; Debarbouille et al., 
1990). The cell cultures were washed and resuspended, to an initial OD600nm of 0.05, in 1.5 mL 
of CSK medium without potassium succinate and supplemented with different carbon and 
energy sources (glucose, arabinose and arabinotriose) at a final concentration of 0.1% (w/v) 
and with IPTG (expression inducer) at 1mM was added when appropriated. The cultures were 
grown in sterile 50 mL Falcon tubes (Sarstedt), incubated at 37 ºC and 150 rpm in an OLS200 
orbital/linear shaking bath (Grant Instruments) and the OD600nm periodically measured in an 
Ultrospec 2100 pro UV/Visible Spectrophotometer (GE Healthcare Life Sciences).. 
Production and purification of recombinant proteins 
E. coli BL21 (DE3) cells harbouring both pMJ22 and pT-GroE were grown at 37 ºC and 150 
rpm in 10 mL of LB medium with antibiotics (small-scale production). When the OD600nm of the 
cultures reached 0.6, 5 mL of each culture were induced by the addition of IPTG to a final 
concentration of 1 mM. Both the induced and non-induced cultures were grown for a further 18 
hours at 25 ºC, and then the cells were harvested by centrifugation at 16000 g for 5 minutes and 
resuspended in 100 μL of Lysis Buffer (20 mM sodium phosphate buffer, pH 7.4, 62.5 mM NaCl, 
100 mM imidazole, glycerol 10% (v/v)). To disrupt the cells, incubation with lysozyme (1 mg/mL) 
at 37 ºC for 10 minutes and three cycles of freezing in liquid nitrogen and thawing for 5 minutes 
at 37 ºC were performed, followed by incubation with 0.02 U/mL of benzonase  (Sigma) and 
PMSF (10 mM) at 37 ºC for 10 minutes. After centrifugation at 9000 g and 4 ºC for 15 minutes, 
the soluble fraction was recovered and the insoluble fraction was resuspended in 100 μL of 
Lysis Buffer. 
E. coli BL21 (DE3) cells harbouring pMJ22 were grown at 37 ºC and 150 rpm in 10 mL of 
LB medium with antibiotics (small-scale production). When the OD600nm of the cultures reached 
0.6, 5 mL of each culture was induced by the addition of IPTG to a final concentration of 0.1 
mM. Both the induced and non-induced cultures were grown for a further 16 hours at 16 ºC, and 
then cells were harvested and lysed as described above. 
 




To purify MsmX, a large-scale induction was performed. E. coli BL21 (DE3) harbouring 
pMJ22 was incubated at 37 ºC and 150 rpm in 1 L of LB medium, using antibiotics. When the 
OD600nm of the cultures reached 0.6, the culture was induced by the addition of IPTG to a final 
concentration of 0.1 mM and grown for a further 16 hours at 16 ºC. The cells were harvested by 
centrifugation at 12000 g. The pellets were resuspended in 10mL of Start Buffer (20 mM Tris-
HCl, pH 7.4, 50 mM NaCl and 10 mM imidazole) and 5 μl of benzonase at 2.5 U/mL were 
added. The cells were lysed by sonication, and then centrifuged at 23500 g (30 minutes and 4 
ºC). The supernatant was filtered using a 0.45 μm filter (Sarstedt) and loaded into a 1mL Hitrap 
Chelating HP column (GE Healthcare).  The bound proteins were eluted with a discontinuous 
gradient of imidazole (40 mM, 100 mM, 200 mM, 300 mM and 500 mM).  
To purify MsmX-Lys43Ala, a large-scale induction was performed with E. coli BL21 (DE3) 
harbouring pAM11, using the same conditions as described to MsmX. However the purification 
protocol was slightly changed instead of using the 20 mM Tris-HCl buffers, a 10 mM sodium 
phosphate and 500 mM NaCl, were used. 
Protein analysis 
The analysis of the production, purification and molecular mass of the enzymes (monomers 
and/or oligomers) was performed with SDS-PAGE (stained with Coomassie Blue), using Low 
Molecular Weight Protein Marker (NZYTech). The protein quantification was determined using 
Bio-Rad Protein Assay (Bio-Rad Laboratories, Inc). 
ATPase activity assay 
Purified MsmX and MsmX-Lys43Ala were assayed for ATP hydrolysis by monitoring the 
production of inorganic phosphate at 37 °C in 20 mM Tris-HCl, pH 7.4, 50 mM NaCl and 10 mM 
MgCl2. MsmX-Lys43Ala was stored in sodium phosphate buffer which was changed to the 
assays buffer using PD-10 Desalting Columns (GE Healthcare Life Sciences). Activity assays 
were performed with 5 μg of total protein and 0.1 mM ATP. 
The assay mixture was incubated at 37ºC for 3h, with inorganic phosphate being measured 
at 0 h, 1 h, 2 h and 3 h. The quantification of inorganic phosphate was determined using the 
Malachite Green Phosphate Detection Kit (R&D Systems, Minneapolis, MN, USA) in 
accordance with the manufacturer’s instructions. Background phosphate levels were monitored 
in parallel using a control reaction without protein. OD620nm was measured in an Ultrospec 2100 
pro UV/Visible Spectrophotometer (GE Healthcare Life Sciences).  
 
 




3.3. Results and Discussion 
Sequence Analysis 
MsmX, which can be transcribed monocistronicaly, encodes a 365 aa with a molecular 
weight of ~41 kDa and an isoelectric point of 7.385 (http://subtiwiki.uni-goettingen.de; Michna et 
al., 2014). MsmX is highly similar (>40% identity) to MalK from E. coli and a protein sequence 
alignment of MsmX and  MalK  highlights  the  most  conserved  residues (Figure 2.1). 
The characteristic motifs of ATP-binding proteins family are indicated in the alignment: 
Walker A and B, Q-loop, Signature, D-loop and H-loop. Although these motifs are highly 
conserved in both proteins, as observed in this type of ATPases, there are some minor 
differences. In the Q-loop there is a semi-conservative substitution on position 84 (Asn to Ser), 
while in Walker B occurs a conservative substitution in position 158 (Met to Leu), maintaining 
the hydrophobic characteristic necessary for that position. Three amino acids in the H-loop were 
substituted by amino acids with distinct characteristics but maintaining the conserved histidine. 
The online tool PSIpred, which predicts secondary structures, was used to compare MsmX 
and MalK (Jones, 1999; McGuffin et al., 2000; Bryson et al., 2005) and the results are shown in 
Figure 2.2. The structures predicted with the program are highly similar from the N-terminus to 
the H-loop motif. From this motif towards the C-terminal some differences are noticed in the 
structure, with MsmX displaying three additional α-helices. The C-terminal domain of MalK is 
known to be involved in regulatory processes through interactions with regulatory proteins 
(Biemans-Oldehinkel et al., 2006). 
 





Figure 3.1 - MsmX and MalK sequence alignment. The amino acid sequences of MsmX and MalK 
from E.  coli were aligned using ClustalW2  (Thompson et al., 1994).  Identical amino acids are marked 
with a red asterisk, while substitutions with residues displaying the same properties are marked with ”:” and 
semi-conservative substitutions are marked with a “.“. Gaps in the amino acid sequence are represented 
by a ”–“. The conserved motifs are labeled in colors. The red arrow indicates the mutation performed in 
























Figure 3.2 – MsmX secondary structure prevision by PSIpred. On the left is the predicted 
secondary structure for MsmX and on the right for MalK. 
 
Expression of msmX in E. coli 
Previously, a recombinant version of MsmX (rMsmX) with a H6-tag at the C-terminal was 
constructed and expressed in E. coli using the pET30 vector. The preliminary data showed that 
rMsmX was functional in B. subtilis, however the soluble amount of protein obtained when 
expressed in E. coli was low (Ferreira and Sá-Nogueira, unpublished results). When producing 
this protein at 37 ºC with a 4 hour induction a considerable amount of protein was produced, but 
almost all the protein was in the insoluble fraction. 
 




The low levels of soluble protein could be due to: i) the protein is not being able to achieve 
its natural folding which is making the protein to be targeted to inclusion bodies, ii) although this 
protein is cytoplasmic it can interact with membrane proteins from E. coli or iii) because this type 
of proteins usually have a residual ATPase activity, the production of high amounts of protein 
could be disrupting the energetic balances in the cell. In order to improve solubility we tested 
different expression conditions. First, we co-expressed GroESL chaperones, encoded by the 
pT-GroE plasmid, together with MsmX, and secondly we reduced the protein synthesis rate, by 
lowering the growth temperature, and the IPTG (inducer) concentration (Figure 3.3). 
The results indicate that both strategies improve solubility, however the reduction of protein 
synthesis seems to have a higher effect on protein solubility. Although the total amount of 
protein is lower in these conditions, the proportion of soluble protein is higher and should result 




Figure 3.3 – Overproduction of rMsmX in E. coli BL21 (DE3). On the left are shown the cell 
extracts from co-expression of rMsmX and GroESL chaperones at 30 ºC for 4 h with 1 mM IPTG. On the 
right are displayed the cell extracts from expression of rMsmX at 16 ºC for 16 h with 0.1 mM IPTG. P – 
Insoluble Fraction; SN – Soluble Fraction; - IPTG – IPTG not added; +IPTG – IPTG added; LMW - Low 
Molecular Weight Protein Marker (NZYTech). Extracts run in a 12.5% SDS-PAGE, stained with Coomassie 
Blue. Soluble rMsmX is indicated with black triangle. 
 
 
These results suggest that the protein insolubility may be derived from a defensive 
response of the cell against the energetic balances disruption induced by over-expression of a 
heterologous ATPase. Decreasing the rate of protein synthesis lead to smaller amounts of 
ATPase and, consequently, decreased the toxic effect in the cell. However, we cannot discard 
 




possible interactions with membrane proteins because in the new conditions we still have more 
insoluble protein than soluble, which could be explained by these interactions. In conclusion, 
large-scale overproduction of rMsmX, for protein purification, was conducted by induction with 
0.1 mM IPTG during 16 h at 16 ºC. 
Purification of MsmX in E. coli 
Usually, we perform protein purifications in a sodium phosphate buffer (PBS), however with 
this protein we decided to use Tris-HCl buffer because inorganic phosphate will interfere with 
the assay for ATPase activity determination. In the purification it was used a Ni-NTA column, as 
described in the Materials and Methods section, which exclusively binds to the H6-Tag from 
rMsmX.  
As shown in Figure 3.4, it was possible to obtain rMsmX with a high degree of purity, 
although some contaminant proteins are present. These persistent contaminants could be due 
to interactions of those proteins with exposed hydrophobic regions of rMsmX. Elution of rMsmX 
initiated at 200 mM of imidazole and persisted until 500 mM of imidazole. In the flow-through 
and the wash fraction we observe the rMsmX band, which represents loss of protein, in addition 
it is possible that some protein remained in the column since in the last elution fraction there 
was still protein. These observations indicate that it is necessary to optimize the purification 
protocol. Possible changes are the increase of Tris-HCl concentration and/or alter the number 




Figure 3.4 – Purification of rMsmX. rMsmX was overexpressed, by largescale induction, in E. coli 
BL21 (DE3) harbouring pMJ22 and resulting protein extracts were purified in Ni-NTA column. P and SN 
represent the non-purified insoluble and soluble fractions, respectively; FT represents unbound proteins 
from the soluble fraction (flow-through); W represents washed and weakly bound proteins; 40 mM (1 to 5), 
100 mM (1 to 5), 200 mM (1 to 5), 300 mM (1 to 5) and 500 mM (1 to 5) represent fractions eluted with, 
respectively, 40 mM, 100 mM, 200 mM, 300 mM and 500 mM imidazole. LMW represents the Low 
Molecular Weight Protein Marker (NZYTech). Fractions run in a 12.5% SDS-PAGE, stained with 
Coomassie Blue. rMsmX is indicated with black triangle. 
 




Analysis of the MsmX-Lys43Ala variant in vivo and in vitro  
In the Walker A motif there is a highly conserved Lys at position 43 thought to be 
responsible for ATP stabilization in the active site (see Chapter I). To evaluate its impact in the 
ATPase activity of MsmX, we exchanged this residue to an Ala. The msmX allele present in 
both pAM4 and pMJ22 was mutated to evaluate the effects of such mutation in vivo and in vitro. 
To study the effects in vivo we applied the same methodology used to test the MsmX 
homologs (Chapter II), and a strain with the msmX(Lys43Ala) mutant allele under the control of 
the pSpank(hy), inserted in amyE locus, was constructed (IQB675). The kinetic parameters of 
growth were calculated and are shown in Table 3.4. 
The doubling time of IQB675 in the presence of glucose and arabinose are similar to the 
strain IQB673, which contains the wild-type msmX in the amyE locus. However, when IPTG was 
added to the medium in the presence of arabinotriose, while IQB673 is able to grow in these 
conditions, no growth was observed in strain IQB675 (Figure 3.5).  
 
 
Table 3.4 – Growth of IQB673 and IQB675 in the presence of several saccharides as sole 
carbon/energy. 
Carbon Source 
Doubling Time (minutes)* 
IQB673                                          
(ΔmsmX::cat ΔamyE::pSpank(hy)-
msmX) 
IQB675                                          
(ΔmsmX::cat ΔamyE::Pspank(hy)-
msmX(Lys43Ala)) 
Glucose 0.1% 58.38±2.24 59.55±0.58 
Glucose 0.1% + IPTG 1mM 59.07±1.97 59.81±0.68 
Arabinose 0.1% 78.47±3.47 77.21±1.68 
Arabinose 0.1% + IPTG 1mM 77.53±2.95 76.80±1.10 
Arabinotriose 0.1% No Growth No Growth 
Arabinotriose 0.1% + IPTG 1mM 107.60±3.85 No Growth 
* Cells were grown in CSK minimal medium (see Materials and Methods). Growth Kinetics parameters 
were determined and the results represent the average of three independent experiments, except the 
glucose and arabinose growths without IPTG, which were performed only twice (see Annexes for the 
complete data used in the determination of doubling time). IQB673 results are the same presented in table 
5 and are shown here to facilitate comparison. 
 
 





Figure 3.5 – Growth of IQB676 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmX(Lys43Ala)) in CSK 




This result confirms the importance of Lys43 in the functionality of MsmX. Most probably 
the ATPase is being produced by the cell and could interact with the transport system AraNPQ 
in the membrane. However, due to the mutation in Lys43, the ATP hydrolysis necessary for the 
transportation of arabinotriose is impaired. The MsmX Lys43 residue is the conserved Lys 
present in the Walker A motif and corresponds to the amino acid Lys42 of MalK. This amino 
acid is responsible for direct binding with ATP phosphate groups between which the hydrolysis 
occurs (β- and γ-phosphate). Without this amino acid the phosphodiester bond may not be 
placed in the right position relative to the His in the H-loop, making impossible to break it. This 
way the transporter remains in the outward open position. Benaroudj et al. (2013) mutated the 
same Lys of the ATPase LIC12079 from Leptospira interrogans into an Ala (Lys45Ala), which 
resulted in the loss of ATPase activity. 
For the characterization in vitro of the rMsmX(Lys43Ala) variant, large-scale 
overexpression of rMsmX(Lys43Ala) was conducted in the same conditions used for the 
production of rMsmX. Cell extracts analysis by SDS-PAGE showed that the mutation resulted in 
an increase of protein solubility (Figure 3.6). This observation supports the possible existence of 




















A3 0.1% + IPTG
 





Figure 3.6 - Overproduction of rMsmX(Lys43Ala) in E. coli BL21 (DE3). Cell extracts from 
expression of rMsmX(LYS43ALA) at 16 ºC for 16 h with 0.1 mM IPTG. P – Insoluble Fraction; SN – 
Soluble Fraction; - IPTG – IPTG not added; +IPTG – IPTG added; LMW - Low Molecular Weight Protein 
Marker (NZYTech). Extracts run in a 12.5% SDS-PAGE, stained with Coomassie Blue. Soluble 




The methodology used to purify this rMsmX variant was the same applied in the purification 
of the rMsmX, however we experience some complications in the process. The protein 
concentrations were too high for the buffer used in the purification, resulting in total precipitation 
inside the column or immediately after recovery from the column. Due to these results we 
changed the elution buffer from Tris-HCl to PBS. When using the PBS buffer protein 
precipitation did not occur and the results are shown in Figure 3.7. Additionally it was added 
glycerol to the buffer to improve protein stability.  
 
 
Figure 3.7 - Purification of rMsmX(Lys43Ala). rMsmX(Lys43Ala) was overexpressed, by largescale 
induction, in E. coli BL21 (DE3) harbouring pMJ22 and resulting protein extracts were purified in Ni-NTA 
column. P and SN represent the non-purified insoluble and soluble fractions, respectively; FT represents 
unboundproteins from the soluble fraction (flow-through); W represents washed and weakly bound 
proteins; 40 mM (1 to 5), 100 mM (1 to 5), 200 mM (1 to 5), 300 mM (1 to 5) and 500 mM (1 to 5) represent 
fractions eluted with, respectively, 40 mM, 100 mM, 200 mM, 300 mM and 500 mM imidazole. LMW 
represents the Low Molecular Weight Protein Marker (NZYTech). Fractions run in a 12.5% SDS-PAGE, 
stained with Coomassie Blue. rMsmX(Lys43Ala) indicated with black triangle. 
 




Preliminary assays were performed to determine the ATPase activity of both rMsmX and 
rMsmX(Lys43Ala). The assays were made with 5μg of protein in TrisHCl buffer, supplemented 
with 10 mM MgCl2 and 0.1 mM ATP. rMsmX displayed ATPase capability (Figure 3.8), however 
the ATP rate of ATP hydrolysis is 10 times lower than the activity calculated for other proteins of 
the same family (Benaroudj et al., 2013) and optimization of assays conditions is required to 
obtain maximum activity values. The results obtained with the rMsmX(Lys43Ala) showed a 
drastic decrease in ATP hydrolysis, which confirms that the results obtained in vivo with this 
protein resulted from ATPase activity decrease. Nevertheless, more independently assays in 
these conditions must be conducted to confirm these results. 
 
 
Figure 3.8 - ATP hydrolysis by rMsmX and rMsmX(Lys43Ala). ATP hydrolysis was determined 
by measuring the production of inorganic phosphate, as described in Materials and Methods. 5 μg of 





















































4. Concluding Remarks and Future Perspectives 
 
The introduction of antibiotics in the treatment of infectious disease had a great impact in 
medicine saving countless lives. However, the use of antibiotics creates a phenomenon called 
antibiotic pressure which is the emergence of resistant pathogens. Although this side-effect was 
predicted by Fleming, over the years there has been a negligent and abusive use of antibiotics 
(French, 2010). This led to development of multidrug-resistance pathogens like Clostridium 
difficile, Pseudomonas aeruginosas, S. aureus or S. pneumoniae. Also, in some cases, these 
multidrug-resistance pathogens have developed more virulent traits and acquired enhanced 
transmissibility (Davies and Davies, 2010). 
We have reached a point where we must direct our attentions to the discovery of new 
antimicrobials and therapeutic targets. The carbohydrate metabolism of bacteria plays an 
important role in their survival and capacity for colonization and pathogenesis (Buckwalter and 
King, 2012). One potentially attractive target to act against these pathogens is the multitask 
ATPases recently discovered whose inactivation leads to inability to utilize multiple carbon 
sources. This could have a great impact in the pathogen adaptability to the host niche or even 
kill the bacterial by starvation. So a better understanding of these proteins functionality, 
structure and regulation may have a huge impact in combat against multidrug-resistance 
strains. 
In the work we presented, it was shown that MsmX homologs in other pathogenic species 
are able to substitute MsmX in the cell by restoring arabinooligosaccharides uptake in a B. 
subtilis msmX-null mutant strain. The complementation degree varied depending on the protein 
introduced in the strain genome. The B. thuringiensis protein showed to be more capable of fully 
complement MsmX absence while S. aureus and S. pneumoniae proteins were only able to 
partially complement it. Whether this resulted from differences in amino acid sequence that 
affected the interaction with AraNPQ complex or rather from differences in the amount of protein 
produced by the cell still remains unknown. Thus, here we demonstrated that B. subtilis and 
MsmX could be used as a model to better comprehend this sharing of energy-generating 
components between distinct ABC sugar importers. 
Additionally, we proved that MsmX has ATPase activity and that the conserved Lys 43 
present in the Walker A motif is essential for this activity both in vivo and in vitro. Moreover, 
modifications in the N- and C-terminal primary sequence do not affect MsmX functionality or its 
ability to interact with the AraNPQ transporter. In this work we also achieved important results 
towards the improvement of MsmX production and purification processes, which is crucial for 
crystallography studies and biochemical characterization of MsmX that will provide important 
clues or even answers for the main questions arising from the discovery of multitask ATPases.  
 




The work presented here is just the tip of the iceberg regarding to the knowledge about 
these multitask ATPases and the main forces that drove bacteria to develop these type of sugar 
uptake mechanisms/regulation. First, we need to test the proteins used in this work with the new 
system developed because it will allow us to conclude if the differences in the complementation 
results observed are due to dissimilarities in the proteins or in the amount produced in the cell. 
In addition, we must test the YurJ ATPase from B. subtilis, which displays 58% identity with 
MsmX and is suggested to be multitask, as well as other B. subtilis ATPases thought to be 
exclusive to one transporter. The conjunction of all these results may indicate which MsmX 
residues are important for this multi-transporters interaction capability. Simultaneously, the 
initiation of crystallography studies is of major importance to provide insights into this 
mechanism. Finally, it would be interesting to ascertain if MsmX suffers any post-translational 
regulation like MalK does (Biemans-Oldehinkel et al., 2006). The discovery of possible 
regulatory mechanisms that control MsmX activity and their understanding may also reveal 
MsmX regions for possible targeting. 
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Appendix 6.2 - Map of pAM4. Insertion of a 1224bp fragment containing msmX gene (amplified with 









Appendix 6.3 - Map of pAM5. Insertion of a 1272bp fragment containing HD73_4301 gene, from B. 
thuringiensis serovar kurstaki str. HD73 (amplified with the primers ARA744 and ARA745 and digested 






Appendix 6.4 - Map of pAM6. Insertion of a 1215bp fragment containing ugpC, from S. aureus subsp. 
aureus ST398, (amplified with the primers ARA746 and ARA747 and digested with SalI and SphI) between 








Appendix 6.5 - Map of pAM7. Insertion of a 1295bp fragment containing msmK, from S. pneumoniae 
TIGR4, (amplified with the primers ARA748 and ARA749 and digested with SalI and SphI) between the 




Appendix 6.6 - Map of pAM9. Site-directed mutagenesis of pMJ1 using the mutagenic primers set 
ARA769 and ARA770. Mutagenesis generated a unique BglII restriction site in the 4th nucleotide, 








Appendix 6.7 - Map of pAM10. Site-directed mutagenesis of pAM9 using the mutagenic primers set 
ARA771 and ARA772. Mutagenesis generated a unique NheI restriction site in the 11th nucleotide, 




Appendix 6.8 - Map of pAM11. Site-directed mutagenesis of pMJ22 using the mutagenic primers set 









Appendix 6.9 - Map of pAM12. Insertion of a 1224bp fragment containing msmX gene from pAM10 
(amplified with primers ARA741 and ARA742 and digested with SalI and SphI) between the SalI and SphI 





Appendix 6.10 - Map of pAM13. Site-directed mutagenesis of pAM4 using the mutagenic primers set 









Appendix 6.11 - MsmX and MsmX Homologs sequence alignment. The amino acid sequences 
of MsmX and MalK from E.  coli were aligned using ClustalW2  (Thompson et al., 1994).  Identical amino 
acids are marked with a red asterisk, while substitutions with residues displaying the same properties are 
marked with ”:” and semi-conservative substitutions are marked with a “.“. Gaps in the amino acid 
sequence are represented by a ”–“. The conserved motifs are labeled in colors. The red bar indicates the 








Appendix 6.12 - Growth assays of B. subtilis 168T+ (wild-type) using glucose 0.1% (w/v). 
OD600nm plotted vs. time (h). 
 
 
Appendix 6.13 - Growth assays of B. subtilis 168T+ (wild-type) using arabinose 0.1% (w/v). 
OD600nm plotted vs. time (h). 
 
 
Appendix 6.14 - Growth assays of B. subtilis 168T+ (wild-type) using arabinotriose (A3) 0.1% 























































Appendix 6.15 - Growth assays of B. subtilis IQB672 (ΔmsmX::cat ΔamyE::Pspank(hy)) using 
glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.16 - Growth assays of B. subtilis IQB672 (ΔmsmX::cat ΔamyE::Pspank(hy)) using 
arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.17 - Growth assays of B. subtilis IQB672 (ΔmsmX::cat ΔamyE::Pspank(hy)) using 


























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.18 - Growth assays of B. subtilis IQB673 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmX) 
using glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.19 - Growth assays of B. subtilis IQB673 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmX) 
using arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.20 - Growth assays of B. subtilis IQB673 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmX) 


























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.21 - Growth assays of B. subtilis IQB674 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmK) 
using glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.22 - Growth assays of B. subtilis IQB674 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmK) 
using arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.23 - Growth assays of B. subtilis IQB674 (ΔmsmX::cat ΔamyE::Pspank(hy)-msmK) 



























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.24 - Growth assays of B. subtilis IQB675 (ΔmsmX::cat ΔamyE::pSpank(hy)-
msmX(Lys45Ala)) using glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.25 - Growth assays of B. subtilis IQB675 (ΔmsmX::cat ΔamyE::pSpank(hy)-
msmX(Lys45Ala)) using arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.26 - Growth assays of B. subtilis IQB675 (ΔmsmX::cat ΔamyE::pSpank(hy)-



























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.27 - Growth assays of B. subtilis IQB676 (ΔmsmX::cat ΔamyE::Pspank(hy)-




Appendix 6.28 - Growth assays of B. subtilis IQB676 (ΔmsmX::cat ΔamyE::Pspank(hy)-




Appendix 6.29 - Growth assays of B. subtilis IQB676 (ΔmsmX::cat ΔamyE::Pspank(hy)-
msmX(Glu3Ser, Ile364Ser)) using arabinotriose (A3) 0.1% (w/v) and IPTG 1 mM. OD600nm 


























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.30 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-
HD73_4301) using glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.31 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-
HD73_4301) using arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.32 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-



























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.33 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-ugpC) 
using glucose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.34 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-ugpC) 
using arabinose 0.1% (w/v) and IPTG 1 mM. OD600nm plotted vs. time (h). 
 
 
Appendix 6.35 - Growth assays of B. subtilis IQB677 (ΔmsmX::cat ΔamyE::Pspank(hy)-ugpC) 



























































A3 0.1% + IPTG (1)
A3 0.1% (2)
A3 0.1% + IPTG (2)
A3 0.1% (3)
A3 0.1% + IPTG (3)
 




Appendix 6.36 - Genomic context of HD73_4301 from Bacillus thuringiensis. The arrows 
denote the genes present in the msmK gene region. Below each arrow is indicated the putative function of 




Appendix 6.37 - Genomic context of ugpC from Staphylococcus aureus. The arrows 
represent the genes present in the ugpC gene region. Below each arrow is indicated the putative function 




Appendix 6.38 - Genomic context of msmK from Streptococcus pneumoniae. The arrows 
indicate the genes present in the HD73_4301 gene region. Below each arrow is indicated the putative 
function of encoded protein based on BLAST results. 
 
